Kadmon Holdings Inc KDMN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:37 PM EDT
8.62quote price arrow up+0.03 (+0.35%)
Volume
1,457,746
52 week range
3.15 - 9.20
Loading...
  • Open8.62
  • Day High8.70
  • Day Low8.61
  • Prev Close8.59
  • 52 Week High9.20
  • 52 Week High Date09/08/21
  • 52 Week Low3.15
  • 52 Week Low Date11/02/20

Key Stats

  • Market Cap1.519B
  • Shares Out176.24M
  • 10 Day Average Volume2.39M
  • Dividend-
  • Dividend Yield-
  • Beta1.13
  • YTD % Change108.07

KEY STATS

  • Open8.62
  • Day High8.70
  • Day Low8.61
  • Prev Close8.59
  • 52 Week High9.20
  • 52 Week High Date09/08/21
  • 52 Week Low3.15
  • 52 Week Low Date11/02/20
  • Market Cap1.519B
  • Shares Out176.24M
  • 10 Day Average Volume2.39M
  • Dividend-
  • Dividend Yield-
  • Beta1.13
  • YTD % Change108.07

RATIOS/PROFITABILITY

  • EPS (TTM)-0.67
  • P/E (TTM)-12.95
  • Fwd P/E (NTM)-11.68
  • EBITDA (TTM)-117.225M
  • ROE (TTM)-210.70%
  • Revenue (TTM)1.87M
  • Gross Margin (TTM)61.82%
  • Net Margin (TTM)-5,961.77%
  • Debt To Equity (MRQ)696.07%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Kadmon Holdings Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Kadmon Holdings, Inc. is a biopharmaceutical company, which is engaged in discovering, developing, and delivering therapies for unmet medical needs. The Company's clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies. It is developing oral small molecule inhibitors of Rho-associated coiled-coil kinase (ROCK) to treat immune and fibrotic diseases. Its advanced product candidate, Belumosudil (KD025) is an orally...
Tasos Konidaris
Non-Executive Chairman
Harlan Waksal M.D.
President
Steven Meehan
Chief Financial Officer
Gregory Moss Esq.
Executive Vice President
John Ryan M.D., Ph.D.
Executive Vice President
Address
450 E 29th St
New York, NY
10016
United States

Top Peers

SYMBOLLASTCHG%CHG
AXSM
Axsome Therapeutics Inc
40.41-0.71-1.73%
RUBY
Rubius Therapeutics Inc
15.95-0.05-0.34%
ISEE
Iveric Bio Inc
17.64+1.03+6.20%
INO
Inovio Pharmaceuticals Inc
7.18+0.16+2.21%
INBX
Inhibrx Inc
40.04+0.22+0.55%